XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 33.34

-2.1%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (17231)	7/28/2006 6:36:25 PM
From: bob zagorin	of 17367

Xoma Halts Work With Cubist Friday July 28, 5:01 pm ET Xoma Terminates Contract With Cubist Pharma After Cubist Halts HepeX-B Development LEXINGTON, Mass. (AP) -- Biopharmaceutical company Xoma Ltd. said Friday it has halted development work on Cubist Pharmaceuticals Inc.'s Hepatitis B drug candidate, following Cubist's announcement it will no longer invest in HepeX-B because of stringent FDA approval requirements. Both companies are discussing further development options for the drug candidate, Xoma said in a statement. The company issued a contract termination notice to Cubist. The contract dates back to September of 2005, when Xoma signed on to use its antibody development and manufacturing capabilities to develop new processes to make HepeX-B. Shares of Xoma closed at $1.72, unchanged, and shares of Cubist fell 8 cents to close at $23.34 on the Nasdaq.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next